SCHEMBL20568931

SCHEMBL20568931

OCC1COc2c(Cl)ncnc2N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20568928 1.00
SCHEMBL30698021 0.67 CHEK1 (0.33)
SCHEMBL27642723 0.65 CREBBP (0.39)
SCHEMBL13757115 0.65 RIPK1 (0.39)
SCHEMBL30277914 0.64 MTAP (0.31)
SCHEMBL12170631 0.64 RET (0.47)
SCHEMBL3587691 0.64
SCHEMBL9377605 0.61 PDE3B (0.33)
SCHEMBL6701988 0.59 P2RX7 (0.45)
SCHEMBL13330618 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112601752-A Novel inhibitors of MAP4K1 伊克诺斯科学公司 2021-04-02 CN disclosed
EP-3630778-A1 NOVEL INHIBITORS OF MAP4K1 Ichnos Sciences SA (CH) 2020-04-08 EP disclosed
WO-2018215668-A1 NOVEL INHIBITORS OF MAP4K1 GLENMARK PHARMACEUTICALS S.A. (CH) 2018-11-29 WO disclosed